Research on the Application of Electrical Impedance Tomography in Bronchial Challenge Testing

NCT ID: NCT06502405

Last Updated: 2024-07-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-08-01

Study Completion Date

2025-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to examine whether electrical impedance tomography (EIT) was capable of identifying the deteriorated lung function on a regional level during bronchial challenge testing and whether EIT may provide additional information during bronchial challenge testing and identify spatial and temporal heterogeneity of regional lung function.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The content of this study includes:

1. Can EIT identify the uneven ventilation caused by airway contraction in patients during bronchial provocation tests.
2. Can EIT monitor airway contraction in patients before Spirometer examination after inhaling activators.
3. Can EIT observe uneven ventilation caused by airway contraction through tidal breathing after the patient inhales activator.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients suspected of asthma who require bronchial challenge testing.
2. The Bronchodilator responsiveness testing is negative.
3. patients with a pre-bronchodilator FEV1 \>60% predicted.
4. No contraindications for bronchial provocation test examination.
5. Fully understand the purpose and significance of this study, and voluntarily participate in the research.

Exclusion Criteria

1\. patients with a pre-bronchodilator FEV1≤60% predicted.

1. Contraindications for bronchial challenge testing.
2. Pregnant or lactating women.
3. After pacemaker surgery.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

wang kaifei

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

wang kaifei

Deputy chief physician

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Fei Xie, Dr

Role: STUDY_DIRECTOR

Chinese PLA General Hospital

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lu Cao, Master

Role: CONTACT

13810389517

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EIT and PFTs

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.